Suppr超能文献

免疫介导的炎症性疾病诊断前精神障碍发病率的上升。

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.

机构信息

Department of Internal Medicine,Max Rady College of Medicine,Rady Faculty of Health Sciences,University of Manitoba,Winnipeg,Canada.

Manitoba Centre for Health Policy,Max Rady College of Medicine,Rady Faculty of Health Sciences,University of Manitoba,Winnipeg,Canada.

出版信息

Epidemiol Psychiatr Sci. 2019 Jun;28(3):333-342. doi: 10.1017/S2045796017000579. Epub 2017 Nov 3.

Abstract

AIMS

After the diagnosis of immune-mediated inflammatory diseases (IMID) such as inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA), the incidence of psychiatric comorbidity is increased relative to the general population. We aimed to determine whether the incidence of psychiatric disorders is increased in the 5 years before the diagnosis of IMID as compared with the general population.

METHODS

Using population-based administrative health data from the Canadian province of Manitoba, we identified all persons with incident IBD, MS and RA between 1989 and 2012, and cohorts from the general population matched 5 : 1 on year of birth, sex and region to each disease cohort. We identified members of these groups with at least 5 years of residency before and after the IMID diagnosis date. We applied validated algorithms for depression, anxiety disorders, bipolar disorder, schizophrenia, and any psychiatric disorder to determine the annual incidence of these conditions in the 5-year periods before and after the diagnosis year.

RESULTS

We identified 12 141 incident cases of IMID (3766 IBD, 2190 MS, 6350 RA) and 65 424 matched individuals. As early as 5 years before diagnosis, the incidence of depression [incidence rate ratio (IRR) 1.54; 95% CI 1.30-1.84) and anxiety disorders (IRR 1.30; 95% CI 1.12-1.51) were elevated in the IMID cohort as compared with the matched cohort. Similar results were obtained for each of the IBD, MS and RA cohorts. The incidence of bipolar disorder was elevated beginning 3 years before IMID diagnosis (IRR 1.63; 95% CI 1.10-2.40).

CONCLUSION

The incidence of psychiatric comorbidity is elevated in the IMID population as compared with a matched population as early as 5 years before diagnosis. Future studies should elucidate whether this reflects shared risk factors for psychiatric disorders and IMID, a shared final common inflammatory pathway or other aetiology.

摘要

目的

在诊断出免疫介导的炎症性疾病(IMID),如炎症性肠病(IBD)、多发性硬化症(MS)和类风湿关节炎(RA)后,与一般人群相比,精神共病的发病率增加。我们旨在确定在 IMID 诊断前的 5 年内,精神障碍的发病率是否高于一般人群。

方法

利用来自加拿大马尼托巴省的基于人群的行政健康数据,我们确定了 1989 年至 2012 年间所有新发 IBD、MS 和 RA 患者,以及与每个疾病队列在出生年份、性别和地区上 5:1 匹配的一般人群队列。我们确定了这些群体中至少有 5 年居住时间的成员,在 IMID 诊断日期之前和之后。我们应用了经过验证的抑郁症、焦虑障碍、双相情感障碍、精神分裂症和任何精神障碍的算法,以确定这些疾病在诊断前 5 年和诊断后 5 年的年度发病率。

结果

我们确定了 12141 例新发 IMID(3766 例 IBD、2190 例 MS、6350 例 RA)和 65424 例匹配个体。早在诊断前 5 年,IMID 队列中抑郁症(发病率比 1.54;95%可信区间 1.30-1.84)和焦虑障碍(发病率比 1.30;95%可信区间 1.12-1.51)的发病率就高于匹配队列。IBD、MS 和 RA 队列也得到了类似的结果。双相情感障碍的发病率在 IMID 诊断前 3 年就开始升高(发病率比 1.63;95%可信区间 1.10-2.40)。

结论

与匹配人群相比,IMID 人群早在诊断前 5 年就出现了精神共病发病率的升高。未来的研究应该阐明这是否反映了精神障碍和 IMID 的共同风险因素、共同的最终炎症途径或其他病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a304/7032785/b406aab0fa1f/S2045796017000579_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验